PECULIARITIES OF THERAPY WITH LONG ACTING β2-ADRENERGIC AGONISTFORMOTEROL FOR ASTHMA IN CHILDREN
Abstract
Information on clinical use of long acting β2-adrenergic agonist formoterol in children with asthma is presented. Pharmacokinetics and pharmacodymanics are scrutinized in detail. Combined therapy for asthma with formoterol and inhaled corticosteroids is spotlighted.
Key words: formoterol, asthma, children.
Key words: formoterol, asthma, children.
About the Authors
Yu.G. Levina
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
L.S. Namazova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
V.V. Botvin'eva
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
N.I. Voznesenskaya
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
R.M. Torshkhoeva
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
K.E. Efendieva
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Review
For citations:
Levina Yu., Namazova L., Botvin'eva V., Voznesenskaya N., Torshkhoeva R., Efendieva K. PECULIARITIES OF THERAPY WITH LONG ACTING β2-ADRENERGIC AGONISTFORMOTEROL FOR ASTHMA IN CHILDREN. Pediatric pharmacology. 2006;3(4):42-49.
Views:
439
Email this article 